Literature DB >> 18286287

High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-alpha in lung cancer.

R B Baleeiro1, L B Anselmo, F A Soares, C A L Pinto, O Ramos, J L Gross, F Haddad, R N Younes, M Y Tomiyoshi, P C Bergami-Santos, J A M Barbuto.   

Abstract

INTRODUCTION: Antigen-presenting cells, like dendritic cells (DCs) and macrophages, play a significant role in the induction of an immune response and an imbalance in the proportion of macrophages, immature and mature DCs within the tumor could affect significantly the immune response to cancer. DCs and macrophages can differentiate from monocytes, depending on the milieu, where cytokines, like interleukin (IL)-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF) induce DC differentiation and tumor necrosis factor (TNF)-alpha induce DC maturation. Thus, the aim of this work was to analyze by immunohistochemistry the presence of DCs (S100+ or CD1a+), macrophages (CD68+), IL-4 and TNF-alpha within the microenvironment of primary lung carcinomas.
RESULTS: Higher frequencies of both immature DCs and macrophages were detected in the tumor-affected lung, when compared to the non-affected lung. Also, TNF-alpha-positive cells were more frequent, while IL-4-positive cells were less frequent in neoplastic tissues. This decreased frequency of mature DCs within the tumor was further confirmed by the lower frequency of CD14-CD80+ cells in cell suspensions obtained from the same lung tissues analyzed by flow cytometry.
CONCLUSION: These data are discussed and interpreted as the result of an environment that does not oppose monocyte differentiation into DCs, but that could impair DC maturation, thus affecting the induction of effective immune responses against the tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286287     DOI: 10.1007/s00262-008-0468-7

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  17 in total

1.  Myeloid-Derived Lymphatic Endothelial Cell Progenitors Significantly Contribute to Lymphatic Metastasis in Clinical Breast Cancer.

Authors:  Lisa Volk-Draper; Radhika Patel; Nihit Bhattarai; Jie Yang; Andrew Wilber; David DeNardo; Sophia Ran
Journal:  Am J Pathol       Date:  2019-08-15       Impact factor: 4.307

2.  Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Authors:  Jacob Osterbur; Leslee Sprague; Maria Muccioli; Michelle Pate; Kristen Mansfield; John McGinty; Yihan Li; Yandi Li; Venktesh Shirure; Maria Cecilia Courreges; Fabian Benencia
Journal:  Immunobiology       Date:  2012-02-27       Impact factor: 3.144

3.  CD1a and CD1d genes polymorphisms in breast, colorectal and lung cancers.

Authors:  Hossein Golmoghaddam; Abdul Mohammad Pezeshki; Abbas Ghaderi; Mehrnoosh Doroudchi
Journal:  Pathol Oncol Res       Date:  2011-01-22       Impact factor: 3.201

4.  miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma.

Authors:  Hao Zhang; Yan Liu; Zhihong Xu; Quan Chen
Journal:  Int J Gen Med       Date:  2022-03-29

5.  Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.

Authors:  Chan-Zhen Liu; Li Zhang; Xiao-Hong Chang; Ye-Xia Cheng; Hong-Yan Cheng; Xue Ye; Tian-Yun Fu; Jun Chen; Heng Cui
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

Review 6.  Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment.

Authors:  Ramin Lotfi; Christof Kaltenmeier; Michael T Lotze; Christoph Bergmann
Journal:  Transfus Med Hemother       Date:  2016-03-08       Impact factor: 3.747

7.  Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study.

Authors:  Maurício W Perroud; Helen N Honma; Aristóteles S Barbeiro; Simone Co Gilli; Maria T Almeida; José Vassallo; Sara To Saad; Lair Zambon
Journal:  J Exp Clin Cancer Res       Date:  2011-06-17

Review 8.  Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.

Authors:  Fabian Benencia; Leslee Sprague; John McGinty; Michelle Pate; Maria Muccioli
Journal:  J Biomed Biotechnol       Date:  2012-03-15

9.  Dendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC.

Authors:  Soyoung Baek; Seog Jae Lee; Myoung Joo Kim; Hyunah Lee
Journal:  Immune Netw       Date:  2012-12-31       Impact factor: 6.303

Review 10.  What are the molecules involved in regulatory T-cells induction by dendritic cells in cancer?

Authors:  Rodrigo Nalio Ramos; Cristiano Jacob de Moraes; Bruna Zelante; José Alexandre M Barbuto
Journal:  Clin Dev Immunol       Date:  2013-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.